- Home
- LASR vs RLAY Comparison
LASR vs RLAY Comparison
Compare LASR & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASR
- RLAY
- Stock Information
- Founded
- LASR 2000
- RLAY 2015
- Country
- LASR United States
- RLAY United States
- Employees
- LASR N/A
- RLAY N/A
- Industry
- LASR Semiconductors
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LASR Technology
- RLAY Health Care
- Exchange
- LASR Nasdaq
- RLAY Nasdaq
- Market Cap
- LASR 903.8M
- RLAY 803.4M
- IPO Year
- LASR 2018
- RLAY 2020
- Fundamental
- Price
- LASR $29.97
- RLAY $6.62
- Analyst Decision
- LASR Strong Buy
- RLAY Strong Buy
- Analyst Count
- LASR 6
- RLAY 8
- Target Price
- LASR $27.42
- RLAY $17.25
- AVG Volume (30 Days)
- LASR 839.3K
- RLAY 1.6M
- Earning Date
- LASR 11-06-2025
- RLAY 11-05-2025
- Dividend Yield
- LASR N/A
- RLAY N/A
- EPS Growth
- LASR N/A
- RLAY N/A
- EPS
- LASR N/A
- RLAY N/A
- Revenue
- LASR $216,913,000.00
- RLAY $8,355,000.00
- Revenue This Year
- LASR $23.44
- RLAY $27.33
- Revenue Next Year
- LASR $8.73
- RLAY $8.87
- P/E Ratio
- LASR N/A
- RLAY N/A
- Revenue Growth
- LASR 9.79
- RLAY N/A
- 52 Week Low
- LASR $6.20
- RLAY $1.78
- 52 Week High
- LASR $32.27
- RLAY $7.07
- Technical
- Relative Strength Index (RSI)
- LASR 55.32
- RLAY 85.24
- Support Level
- LASR $28.74
- RLAY $5.47
- Resistance Level
- LASR $31.70
- RLAY $5.42
- Average True Range (ATR)
- LASR 1.39
- RLAY 0.29
- MACD
- LASR -0.21
- RLAY 0.14
- Stochastic Oscillator
- LASR 51.45
- RLAY 98.45
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).